Your browser doesn't support javascript.
loading
Intermediate filaments enable pathogen docking to trigger type 3 effector translocation.
Russo, Brian C; Stamm, Luisa M; Raaben, Matthijs; Kim, Caleb M; Kahoud, Emily; Robinson, Lindsey R; Bose, Sayantan; Queiroz, Ana L; Herrera, Bobby Brooke; Baxt, Leigh A; Mor-Vaknin, Nirit; Fu, Yang; Molina, Gabriel; Markovitz, David M; Whelan, Sean P; Goldberg, Marcia B.
Affiliation
  • Russo BC; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Stamm LM; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Raaben M; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Kim CM; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Kahoud E; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Robinson LR; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Bose S; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Queiroz AL; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Herrera BB; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Baxt LA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Mor-Vaknin N; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Fu Y; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Molina G; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Markovitz DM; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.
  • Whelan SP; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Goldberg MB; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Nat Microbiol ; 1: 16025, 2016 Mar 07.
Article in En | MEDLINE | ID: mdl-27572444
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salmonella typhimurium / Shigella flexneri / Vimentin / Bacterial Adhesion / Yersinia pseudotuberculosis / Virulence Factors / Type III Secretion Systems Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nat Microbiol Year: 2016 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salmonella typhimurium / Shigella flexneri / Vimentin / Bacterial Adhesion / Yersinia pseudotuberculosis / Virulence Factors / Type III Secretion Systems Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nat Microbiol Year: 2016 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido